SpeechPathology.com Phone: 800-242-5183

Sunbelt Staffing Banner - December 2020

Understanding Dementia

Barbara E. Weinstein, PhD

November 4, 2019



What is dementia? Is it a disease, a term synonymous with Alzheimer's disease or an umbrella term for a group of symptoms involving cognitive deterioration?


All of these answers are right. It is a general term, and it is an umbrella term for a range of conditions that affect the brain. It is a group of symptoms affecting the ability to process thought.  It affects memory, as well as thinking, behavior and social activities - severely enough to interfere with daily living and independent living.

Some characteristics of dementia are that it is progressive, it is gradual in onset and often overlooked. Communication is impaired. People with dementia have difficulty performing activities of daily living. There is memory loss, impaired reasoning, and a decline in the ability to learn new information. Physicians say that when it is serious enough to affect at least two cognitive functions such as memory, attention, thinking, or language, that is when dementia has started showing its face.

The decline and the trajectory of dementia is interesting. It is not a normal part of aging. With normal aging, there is a slight decline in cognition. Then as some people age, they develop mild cognitive impairment (MCI). A significant percentage of people with mild cognitive impairment progress on to dementia, and become unable to function independently and perform activities of daily living. It is the decline in function that distinguishes between MCI and dementia - the inability to take care of oneself and to function independently.

Dementia is multi-factorial. It affects all regions of the brain and connections between the different regions of the brain. For example, the parietal lobe is affected, and so we can see the communication difficulty; impairment in the frontal lobe leads to problems in judgment and execution of basic tasks; impairment in the temporal lobe interferes with language, hearing, and recognition; and the effect on the hippocampus interferes with new memory.

Alzheimer’s is the major cause of dementia, accounting for about 60% to 80% of dementia cases. But, because it is a highly variable condition, it is under-detected in primary care. It is typically only detected at the later stages. The Gerontological Society and the Alzheimer's Society have developed a toolkit for helping primary care doctors recognize and identify dementia earlier.

There are individual differences in the amount of pathology required for the initial expression of clinical symptoms. It is very important to understand that there are significant differences between individuals with regard to when the pathology expresses itself. Some people with neuropathological brain changes do not have dementia. Individuals who have good cognitive reserves can tolerate more neuropathology before they develop dementia. This is significant, and this is why it is very important to encourage patients to remain engaged; engagement is protective against a decline in cognition. Less cognitive reserve leads to earlier development of dementia. The reserve that people demonstrate may be related to the anatomical substrate of the brain, to cognitive adaptation, or to resilience.  There are a number of variables that influence this.

Engagement in leisure activities really makes a difference in terms of the onset of cognitive decline. If individuals participate in six or fewer leisure activities they are at greater risk for developing dementia, as compared to individuals who engage in more than six leisure activities. Engagement is very important because it contributes to cognitive activity, which strengthens the functioning and plasticity of neural circuits.

Please refer to the SpeechPathology.com course, A Dementia Primer for Speech-Language Pathologists, for more information on dementia, its connections to hearing loss, and therapeutic modifications SLPs can employ to optimize audibility and communication.

barbara e weinstein

Barbara E. Weinstein, PhD

Professor Barbara E. Weinstein is a Professor of Audiology at the Graduate Center, CUNY in NYC and an Adjunct Professor of Medicine at NYU School of Medicine. Dr. Weinstein received her Ph.D. from Columbia University where she began her academic career as a young faculty member.  A recipient of numerous national and international awards, Professor Weinstein developed the Hearing Handicap Inventories, the world’s most widely used tools to identify patients with hearing loss which has been translated into 20+ different languages.  Dr. Weinstein’s primary research interests include hearing loss, dementia and social isolation, screening for age related hearing loss and quantification of patient reported outcomes. Dr. Weinstein has long advocated for the integration of hearing health care into the mainstream be it cultural, medical or religious institutions.  Her research on hearing loss and dementia, and on the social consequences of hearing loss, have profound implications at the intersection of audiology, medicine and society.


Related Courses

A Dementia Primer for Speech-Language Pathologists
Presented by Barbara E. Weinstein, PhD


Barbara E. Weinstein, PhD
Course: #8732Level: Intermediate1 Hour
  'I came to the course with very little experience, and now feel like I have a foundation for continued study'   Read Reviews
Age-related hearing loss (ARHL) has been identified as a potentially modifiable risk factor for dementia. ARHL and dementia are costly conditions because of their marked impact on social functioning, health outcomes and well-being. This course will provide an overview of dementia, its connections to hearing loss, and therapeutic modifications SLPs can employ to optimize audibility and communication.

Listening Effort, Fatigue, Social Isolation, & Dementia: Correlates of Age Related Hearing Loss
Presented by Barbara E. Weinstein, PhD


Barbara E. Weinstein, PhD
Course: #8503Level: Intermediate1 Hour
  'Useful on both a personal and professional level'   Read Reviews
A hallmark of age related hearing loss is difficulty understanding in noisy environments. The difficulty requires significant listening effort on the listener’s part which, when prolonged, is associated with fatigue. The fatigue in combination with the listening effort and cognitive load often leads people to withdraw from social situations. Social disengagement has many downstream negative outcomes - including dementia - that will be discussed, along with simple solutions for clinical practice.

Behavioral Frameworks for Dementia Management
Presented by Mary Beth Mason, PhD, CCC-SLP, Robert W. Serianni, MS, CCC-SLP, FNAP


Mary Beth Mason, PhD, CCC-SLPRobert W. Serianni, MS, CCC-SLP, FNAP
Course: #9473Level: Intermediate1 Hour
  'great information'   Read Reviews
This course will focus on cognitive-communication intervention strategies for various dementia presentations and will provide a review of evidence-based treatment. Behavioral frameworks along with their rationales will be introduced and applied across several dementia types and mild, moderate and severe levels of impairment.

Assessment of Cognitive-Linguistic Skills: The SLP's Role in Acute Care
Presented by Lisa Mechler, MS, CCC-SLP


Lisa Mechler, MS, CCC-SLP
Course: #8194Level: Introductory1 Hour
  'Information on standardized tests that can be used in acute care!'   Read Reviews
This course will review the rationale for completing cognitive-linguistic evaluations with adults in the acute care setting. Informal and formal assessments will be reviewed, as well as the role of the SLP in a multidisciplinary team.

Research Watch Report: Evidence-Based Treatment Approaches for Acquired Apraxia of Speech
Presented by April Garrity, PhD, CCC-SLP


April Garrity, PhD, CCC-SLP
Course: #9226Level: Advanced1 Hour
  'I learned how mass practice vs distributed practice can affect outcomes'   Read Reviews
This Research Watch Report focuses on some of the most current research in the area of acquired apraxia of speech (AOS). Three research articles are summarized and potential clinical applications of the evidence are discussed.